EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 24 / Numéro 2 (Février 2008) Med Sci (Paris), 24 2 (2008) 169-176 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 24, Numéro 2, Février 2008
Page(s) 169 - 176
Section M/S revues
DOI https://doi.org/10.1051/medsci/2008242169
Publié en ligne 15 février 2008
  1. Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerosis plaque formation in the apoliprotein E-deficient mouse. Proc Natl Acad Sci USA 1997; 94 : 4642–6. [Google Scholar]
  2. Zhou X, Nicoletti A, Elhage R, Hansson GK. Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000; 102 : 2919–22. [Google Scholar]
  3. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 1993; 14 : 426–30. [Google Scholar]
  4. Frostegard J, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques : dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145 : 33–43. [Google Scholar]
  5. Pejnovic N, Vratimos A, Lee SH, et al. Increased atherosclerotic lesions and Th17 cells in interleukin-18 deficient apolipoprotein E-knockout mice fed high-cholesterol diet. Helsinki, Finland, 76th Congress of the European Atherosclerosis Society. Atherosclerosis 2007 : III (suppl) : 13–4. [Google Scholar]
  6. Houtkamp MA, de Boer OJ, van der Loos CM, et al. Adventitial infiltrates associated with advanced atherosclerotic plaques : structural organization suggests generation of local humoral immune responses. J Pathol 2001; 193 : 263–9. [Google Scholar]
  7. Yla-Herttuala S, Palinski W, Butler SW, et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994; 14 : 32–40. [Google Scholar]
  8. Palinski W, Tangirala RK, Miller E, et al. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb 1995; 15 : 1569–76. [Google Scholar]
  9. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339 : 883–7. [Google Scholar]
  10. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993; 341 : 255–9. [Google Scholar]
  11. Stemme S. T lymphocytes-role in atherosclerosis and interactions with vascular cells. University of Gothenburg, 1992. [Google Scholar]
  12. Shaw PX, Horkko S, Chang MK, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105 : 1731–40. [Google Scholar]
  13. Paulsson G, Zhou X, Tornquist E, Hansson GK. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20 : 10–7. [Google Scholar]
  14. Melian A, Geng YJ, Sukhova GK, et al. CD1 expression in human atherosclerosis : a potential mechanism for T cell activation by foam cells. Am J Pathol 1999; 155 : 775–86. [Google Scholar]
  15. Kleindienst R, Xu Q, Willeit J, et al. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993; 142 : 1927–37. [Google Scholar]
  16. Kanwar RK, Kanwar JR, Wang D, et al. Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21 : 1991–7. [Google Scholar]
  17. Benagiano M, D’Elios MM, Amedei A, et al. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol 2005; 174 : 6509–17. [Google Scholar]
  18. George J, Harats D, Gilburd B, et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques : potential implications for lesion progression. Circulation 1999; 99 : 2227–30. [Google Scholar]
  19. Vaarala O, Manttari M, Manninen V, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995; 91 : 23–7. [Google Scholar]
  20. Caligiuri G, Stahl D, Kaveri S, et al. Autoreactive antibody repertoire is perturbed in atherosclerotic patients. Lab Invest 2003; 83 : 939–47. [Google Scholar]
  21. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A. Immune system activation follows inflammation in unstable angina : pathogenetic implications. J Am Coll Cardiol 1998; 32 : 1295–304. [Google Scholar]
  22. Caligiuri G, Paulsson G, Nicoletti A, et al. Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000; 102 : 1114–9. [Google Scholar]
  23. Gupta S, Pablo AM, Jiang XC, et al. IFNg potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 1997; 99 : 2752–561. [Google Scholar]
  24. Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001; 104 : 197–202. [Google Scholar]
  25. Caligiuri G, Rudling M, Ollivier V, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003; 9 : 10–7. [Google Scholar]
  26. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85 : e17–24. [Google Scholar]
  27. Binder CJ, Hartvigsen K, Chang MK, et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 2004; 114 : 427–37. [Google Scholar]
  28. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003; 163 : 1117–25. [Google Scholar]
  29. Kuiper J. European vascular genomics network. Toulouse, France, 2006. [Google Scholar]
  30. Khallou-Laschet J, Caligiuri G, Groyer E, et al. The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease. Arterioscler Thromb Vasc Biol 2006; 26 : 353–8. [Google Scholar]
  31. Rajavashisth T, Qiao JH, Tripathi S, et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J Clin Invest 1998; 101 : 2702–10. [Google Scholar]
  32. Sun J, Sukhova GK, Wolters PJ, et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007; 13 : 719–24. [Google Scholar]
  33. Nicoletti A, Paulsson G, Caligiuri G, Hansson GK. Induction of neonatal tolerance to oxidized-LDL reduces atherosclerosis susceptibility in apoE knockout mice. Mol Med 2000; 6 : 283–90. [Google Scholar]
  34. Zhou X, Caligiuri G, Hamsten A, et al. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21 : 108–14. [Google Scholar]
  35. Caligiuri G, Khallou-Laschet J, Vandaele M, et al. Phosphorylcholine-targeting immunization reduces atherosclerosis. J Am Coll Cardiol 2008; 50 (sous presse). [Google Scholar]
  36. Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation : molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9 : 736–43. [Google Scholar]
  37. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002; 109 : 745–53. [Google Scholar]
  38. Afek A, George J, Gilburd B, et al. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 2000; 14 : 115–21. [Google Scholar]
  39. Schett G, Xu Q, Amberger A, et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995; 96 : 2569–77. [Google Scholar]
  40. Xu Q, Dietrich H, Steiner HJ, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992; 12 : 789–99. [Google Scholar]
  41. Harats D, Yacov N, Gilburd B, et al. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 2002; 40 : 1333–8. [Google Scholar]
  42. George J, Afek A, Gilburd B, et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 1998; 98 : 1108–15. [Google Scholar]
  43. Tupin E, Nicoletti A, Elhage R, et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 2004; 199 : 417–22. [Google Scholar]
  44. Zhou X, Robertson AK, Hjerpe C, Hansson GK. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26 : 864–70. [Google Scholar]
  45. George J, Harats D, Gilburd B, et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 2000; 102 : 1822–7. [Google Scholar]
  46. Nicoletti A, Kaveri S, Caligiuri G, et al. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 1998; 102 : 910–8. [Google Scholar]
  47. Mallat Z, Gojova A, Brun V, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003; 108 : 1232–7. [Google Scholar]
  48. Mallat Z, Gojova A, Marchiol-Fournigault C, et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001; 89 : 930–4. [Google Scholar]
  49. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12 : 178–80. [Google Scholar]
  50. Wyplosz B, Capron L. Aspects infectieux de l’athérosclérose. Med Sci (Paris) 2004; 20 : 169–74. [Google Scholar]
  51. Caligiuri G. Rôle de l’immunité dans l’athérosclérose et dans les syndromes coronariens aigus. Med Sci (Paris) 2004; 20 : 175–81. [Google Scholar]
  52. Mallat Z, Tedgui A. Apoptose et syndromes coronariens aigus. Med Sci (Paris) 2004; 20 : 298–303. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.